ABC-06 (2nd line chemotherapy trial)
Please note: The ABC-06 trial met its recruitment target of 162 patients on 5th January, 2018, and so is no longer recruiting new patients.
The ABC-06 trial is open at a number of centres in the UK. You can find more details and information about eligibility here:
Lead investigator on the ABC-06 trial:
Professor Juan Valle
Professor of Medical Oncology The Christie, Manchester
Department of Medical Oncology
The Christie NHS Foundation Trust
Manchester M20 4BX
Please Note: Patients taking part in either arm of the 2nd line ABC-06 trial may also participate in relevant Phase I trials, if eligible.* (For those patients in the chemotherapy arm, at least 28 days after their last chemotherapy treatment should be allowed.) This should be done in consultation with the ABC-06 trial office.
*See the ABC-06 trial protocol “4.2.3.-Concomitant medication”Back to previous page